279 related articles for article (PubMed ID: 30157945)
1. Can untreated PKU patients escape from intellectual disability? A systematic review.
van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Blau N; Bulut FD; Casas K; Didycz B; Djordjevic M; Federico A; Feillet F; Gizewska M; Gramer G; Hertecant JL; Hollak CEM; Jørgensen JV; Karall D; Landau Y; Leuzzi V; Mathisen P; Moseley K; Mungan NÖ; Nardecchia F; Õunap K; Powell KK; Ramachandran R; Rutsch F; Setoodeh A; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
Orphanet J Rare Dis; 2018 Aug; 13(1):149. PubMed ID: 30157945
[TBL] [Abstract][Full Text] [Related]
2. Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?
van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Casas K; Didycz B; Djordjevic M; Hertecant JL; Leuzzi V; Mathisen P; Nardecchia F; Powell KK; Rutsch F; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31731404
[TBL] [Abstract][Full Text] [Related]
3. Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment.
Khemir S; El Asmi M; Sanhaji H; Feki M; Jemaa R; Tebib N; Dhondt JL; Ben Dridi MF; Mebazaa A; Kaabachi N
Clin Neurol Neurosurg; 2011 Nov; 113(9):727-30. PubMed ID: 21862209
[TBL] [Abstract][Full Text] [Related]
4. A new therapy prevents intellectual disability in mouse with phenylketonuria.
Pascucci T; Rossi L; Colamartino M; Gabucci C; Carducci C; Valzania A; Sasso V; Bigini N; Pierigè F; Viscomi MT; Ventura R; Cabib S; Magnani M; Puglisi-Allegra S; Leuzzi V
Mol Genet Metab; 2018 May; 124(1):39-49. PubMed ID: 29661557
[TBL] [Abstract][Full Text] [Related]
5. Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet.
Lee PJ; Amos A; Robertson L; Fitzgerald B; Hoskin R; Lilburn M; Weetch E; Murphy G
J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):631-5. PubMed ID: 19204028
[TBL] [Abstract][Full Text] [Related]
6. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
[TBL] [Abstract][Full Text] [Related]
7. The natural history of untreated phenylketonuria over 20 years.
Pitt DB; Danks DM
J Paediatr Child Health; 1991 Jun; 27(3):189-90. PubMed ID: 1909536
[TBL] [Abstract][Full Text] [Related]
8. An investigation into diet treatment for adults with previously untreated phenylketonuria and severe intellectual disability.
Fitzgerald B; Morgan J; Keene N; Rollinson R; Hodgson A; Dalrymple-Smith J
J Intellect Disabil Res; 2000 Feb; 44 ( Pt 1)():53-9. PubMed ID: 10711650
[TBL] [Abstract][Full Text] [Related]
9. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
[TBL] [Abstract][Full Text] [Related]
10. Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justification hypothesis".
Scriver CR; Cole DE; Houghton SA; Levy HL; Grenier A; Laberge C
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6175-8. PubMed ID: 6934544
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
[TBL] [Abstract][Full Text] [Related]
12. Neurological manifestations in adults with phenylketonuria: new cases and review of the literature.
Jaulent P; Charriere S; Feillet F; Douillard C; Fouilhoux A; Thobois S
J Neurol; 2020 Feb; 267(2):531-542. PubMed ID: 31701331
[TBL] [Abstract][Full Text] [Related]
13. Undiagnosed maternal phenylketonuria: own clinical experience and literature review.
Bouchlariotou S; Tsikouras P; Maroulis G
J Matern Fetal Neonatal Med; 2009 Oct; 22(10):943-8. PubMed ID: 19557660
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria.
Didycz B; Bik-Multanowski M
Acta Biochim Pol; 2017; 64(3):527-531. PubMed ID: 28850634
[TBL] [Abstract][Full Text] [Related]
15. A Chinese family with phenylketonuria and maternal phenylketonuria detected by family screening.
Hsiao KJ; Chen CH; Chiu PC; Huang SC; Wuu KD
Eur J Pediatr; 1986 Oct; 145(5):409-12. PubMed ID: 3792388
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
Cechák P; Hejcmanová L; Rupp A
Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
[TBL] [Abstract][Full Text] [Related]
17. Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in management.
Yıldız Y; Sivri HS
Eur J Pediatr; 2019 Jul; 178(7):1005-1011. PubMed ID: 31053953
[TBL] [Abstract][Full Text] [Related]
18. [An eighteen-year study on phenylketonuria].
Yu WM; Xu L; Li XW; He C; Shen M; Zhang ZX; Jin YY; Zhou ZS; Qiao F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):218-22. PubMed ID: 12905726
[TBL] [Abstract][Full Text] [Related]
19. Intellectual development and academic achievement of children treated early for phenylketonuria.
Berry HK; O'Grady DJ; Perlmutter LJ; Bofinger MK
Dev Med Child Neurol; 1979 Jun; 21(3):311-20. PubMed ID: 467815
[TBL] [Abstract][Full Text] [Related]
20. Natural history of phenylketonuria and influence of early treatment.
Smith I; Wolff OH
Lancet; 1974 Sep; 2(7880):540-4. PubMed ID: 4140266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
